Puma Biotechnology

Long-Shot Breast Cancer Drug Now Promises Fortune, but Not for Big Pharma
Yahoo/Bloomberg
Fri, 07/25/14 - 05:57 pm
breast cancer
Pfizer
neratinib
Puma Biotechnology
Did Pfizer Make A Horrible Business Deal?
Seeking Alpha
Thu, 07/24/14 - 09:58 am
Pfizer
Puma Biotechnology
neratinib
Puma Biotechnology shares more than triple on postive trial data
Marketwatch
Tue, 07/22/14 - 06:03 pm
Puma Biotechnology
breast cancer
neratinib
This Week in Biotech: A Trifecta of Disappointment Mars ASCO While Biogen Scores a Big Victory
Motley Fool
Mon, 06/9/14 - 09:17 am
ASCO
Biogen Idec
Elocate
neratinib
Puma Biotechnology
CO-1686
Clovis Oncology
Tykerb
GSK
Roche
Cancer Conference Winners And Losers
Forbes
Mon, 06/2/14 - 10:38 am
ASCO
GSK
Puma Biotechnology
Merck
Roche
Bristol-Myers Squibb
Kite
Novartis
Juno Therapeutics
Eli Lilly
Clovis Oncology
AstraZeneca
Puma Biotechnology Announces Presentation of Positive PB272 Phase II Data at the 2014 ASCO Annual Meeting
Yahoo/BusinessWire
Sun, 06/1/14 - 11:33 am
Puma Biotechnology
PB272
breast cancer
HER2-positive metastatic breast cancer
Gilead: X-Marks The Spot For Sovaldi Sales
Seeking Alpha
Wed, 04/23/14 - 10:18 am
Gilead Sciences
Sovaldi
hepatitis C
Incyte
Clovis Oncology
Puma Biotechnology
The Biggest Biotech Wins of the Week
Motley Fool
Thu, 04/17/14 - 07:46 am
biotech
Puma Biotechnology
aripiprazole lauroxil
Alkermes
neratinib
Roche
Herceptin
bemaciclib
breast cancer
Eli Lilly
3 Biotech Stocks Falling Like a Knife: Puma Biotechnology, MacroGenics, and Aratana Therapeutics
Motley Fool
Tue, 04/15/14 - 01:50 pm
Puma Biotechnology
Macrogenics
neratinib
Aratana
MGD007
Puma Biotechnology: ISPY2 Data Added Little To The Neratinib Conversation
Seeking Alpha
Tue, 04/15/14 - 10:40 am
Puma Biotechnology
neratinib
breast cancer
Puma drug better than Herceptin in HER2 breast cancers -trial
Reuters
Mon, 04/7/14 - 10:33 am
Herceptin
Puma Biotechnology
HER2 Inhibitor
breast cancer
neratinib
Ignyta: Now Public With A Targeted Oncology Pipeline Poised For Success
Seeking Alpha
Mon, 02/24/14 - 09:19 am
Ignyta
oncology
Clovis Oncology
Ariad Pharmaceuticals
Mirati Therapeutics
Tesaro
Puma Biotechnology
The Zacks Analyst Blog Highlights: Gilead, Cytokinetics, Puma, Biogen and Spectrum Pharmaceuticals
Yahoo/Zacks.com
Thu, 02/13/14 - 09:18 am
Gilead Sciences
Cytokinetics
Puma Biotechnology
Biogen Idec
Spectrum Pharmaceuticals
Puma Biotech Surges on Favorable Patent Ruling
Yahoo/Zacks.com
Mon, 02/10/14 - 05:32 pm
Puma Biotechnology
patents
neratinib
Boehringer Ingelheim
Teva Acquisition Machine Gears Up: Who Is the Next Target?
Yahoo/24-7 Wall St
Wed, 01/22/14 - 08:41 am
Teva Pharmaceuticals
M&A
Idenix
Insmed
NuPathe
InterMune
Puma Biotechnology
UBS Has Nine Biotech Buyout and Merger Candidates
24/7 Wall St
Tue, 01/14/14 - 09:07 am
biotech
M&A
Alexion
Biomarin
Incyte
Medivation
Idenix
Insmed
InterMune
Puma Biotechnology
Vertex Pharmaceuticals
The Best- And Worst-Performing Biotech Stocks Of 2013
Forbes
Thu, 01/2/14 - 10:45 am
biotech
Puma Biotechnology
Acadia
Isis Pharmaceuticals
Infinity Pharmaceuticals
Amarin
Ariad Pharmaceuticals
Aveo Oncology
Biggest Winners in Biotech This Year
Motley Fool
Tue, 12/10/13 - 09:14 am
Acadia
Puma Biotechnology
Alnylam
Celldex Therapeutics
Breast Cancer Drug Data Boosts Puma Biotechnology
Investors.com
Thu, 12/5/13 - 12:01 pm
Puma Biotechnology
breast cancer
neratinib
Taxol
Bristol-Myers Squibb
Roche
Herceptin
The Billion Dollar Molecule
Seeking Alpha
Fri, 09/27/13 - 08:24 am
GSK
Pfizer
Roche
Puma Biotechnology
neratinib
breast cancer

Pages